Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use CYSTARAN® safely and effectively. See full prescribing information for CYSTARAN. CYSTARAN (cysteamine ophthalmic solution) 0.44%, for topical ophthalmic use Initial U.S. Approval: 1994
Medication labelWhy this: Advisory · dailymed-prescription
CYSTARAN® is a cystine-depleting agent indicated for the treatment of corneal cystine crystal accumulation in patients with cystinosis.
- generic_name
- cysteamine hydrochloride
- product_names
- cysteamine hydrochloride
- ndc
- 54482-020, 54482-020-01, 54482-020-02, 54482-035, 54482-035-02
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en